A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
NEURONES operates in the Information Technology Services industry, Technology sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 876M | 876M | 805M | 701M | 684M | 602M |
| Net Income | 57M | 57M | 54M | 55M | 51M | 40M |
| EPS | $2.33 | $2.33 | $2.20 | $1.92 | $1.84 | $1.46 |
| Free Cash Flow | 91M | 91M | 78M | 58M | 76M | 77M |
| ROIC | 102.5% | 63.4% | 49.8% | 40.6% | 39.0% | 31.9% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.10 | 0.11 | 0.09 | 0.09 | 0.08 |
| Dividends/Share | $1.30 | $1.30 | $1.19 | $0.90 | $2.08 | $0.20 |
| Operating Income | 84M | 84M | 82M | 77M | 73M | 60M |
| Operating Margin | 9.6% | 9.6% | 10.2% | 11.0% | 10.6% | 9.9% |
| ROE | 13.9% | 14.3% | 13.7% | 13.4% | 12.2% | 9.7% |
| Shares Outstanding | 24M | 24M | 24M | 28M | 28M | 28M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 602M | 684M | 701M | 805M | 876M | 876M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 60M | 73M | 77M | 82M | 84M | 84M |
| Op. Margin | 9.9% | 10.6% | 11.0% | 10.2% | 9.6% | 9.6% |
| Net Income | 40M | 51M | 55M | 54M | 57M | 57M |
| Net Margin | 6.7% | 7.4% | 7.8% | 6.7% | 6.5% | 6.5% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 31.9% | 39.0% | 40.6% | 49.8% | 63.4% | 102.5% |
| ROE | 9.7% | 12.2% | 13.4% | 13.7% | 14.3% | 13.9% |
| ROA | 6.4% | 7.8% | 8.3% | 7.8% | 7.5% | 7.2% |
| Cash Flow | ||||||
| Op. Cash Flow | 77M | 76M | 58M | 78M | 91M | 91M |
| Free Cash Flow | 77M | 76M | 58M | 78M | 91M | 91M |
| Owner Earnings | 66M | 65M | 45M | 73M | 86M | 86M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 9.8M | 8.9M | 9.0M | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 9.8M | 8.9M | 9.0M | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 5.6M | 57M | 26M | 29M | 31M | 31M |
| Dividend Yield | 0.8% | 5.8% | 2.4% | 2.8% | 2.7% | 3.6% |
| Share Buybacks | 84K | 120K | 107K | 362K | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 1.8M | 2.3M | 3.5M | 4.8M | 5.5M | 5.5M |
| Debt Repayment | 86K | 245K | 333K | 2.8M | 4.6M | 4.6M |
| Balance Sheet | ||||||
| Net Debt | -272M | -277M | -251M | -283M | -313M | -353M |
| Cash & Equiv. | 306M | 313M | 286M | 323M | 353M | 353M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.08 | 0.09 | 0.09 | 0.11 | 0.10 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 412M | 416M | 395M | 386M | 409M | 409M |
| Total Assets | 631M | 670M | 649M | 734M | 784M | 784M |
| Total Liabilities | 219M | 254M | 253M | 348M | 376M | 376M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital | 330M | 330M | 315M | 344M | 362M | 362M |
| Current Assets | 516M | 548M | 533M | 593M | 635M | 635M |
| Current Liabilities | 185M | 218M | 218M | 249M | 273M | 273M |
| Per Share Data | ||||||
| EPS | 1.46 | 1.84 | 1.92 | 2.20 | 2.33 | 2.33 |
| Owner EPS | 2.38 | 2.36 | 1.60 | 3.03 | 3.54 | 3.54 |
| Book Value | 14.97 | 15.13 | 13.98 | 15.95 | 16.87 | 16.87 |
| Cash Flow/Share | 2.81 | 2.77 | 2.05 | 3.23 | 3.76 | 2.34 |
| Dividends/Share | 0.20 | 2.08 | 0.90 | 1.19 | 1.30 | 1.30 |
| Shares Out. | 27.5M | 27.5M | 28.3M | 24.2M | 24.2M | 24.2M |
| Valuation | ||||||
| P/E Ratio | 19.8 | 22.4 | 20.9 | 21.9 | 19.7 | 15.6 |
| P/FCF | 10.3 | 14.9 | 19.5 | 15.0 | 12.2 | 9.7 |
| EV/EBIT | 8.8 | 11.8 | 11.5 | 10.8 | 9.5 | 6.3 |
| Price/Book | 1.9 | 2.7 | 2.9 | 3.0 | 2.7 | 2.2 |
| Price/Sales | 1.3 | 1.7 | 1.6 | 1.5 | 1.3 | 1.0 |
| FCF Yield | 9.7% | 6.7% | 5.1% | 6.7% | 8.2% | 10.3% |
| Market Cap | 796M | 1.1B | 1.1B | 1.2B | 1.1B | 884M |
| Avg. Price | 25.43 | 35.84 | 37.61 | 42.49 | 47.89 | 36.50 |
| Year-End Price | 28.90 | 41.22 | 39.96 | 48.37 | 45.89 | 36.50 |
NEURONES passes 7 of 9 quality checks, indicating strong fundamentals.
NEURONES trades at 15.6x trailing earnings, compared to its 15-year median P/E of 20.9x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 9.7x vs a median of 14.9x. The company's 5-year average ROIC is 45.0%. Total shareholder yield (dividends) is 3.6%. At current prices, the estimated annualized return to fair value is +3.9%.
NEURONES (NRO-PA) has a current P/E ratio of 15.6, compared to its historical median P/E of 20.9. The stock is currently considered Cheap based on its historical valuation range.
NEURONES (NRO-PA) has a 5-year average return on invested capital (ROIC) of 45.0%. This indicates strong capital allocation and a potential competitive advantage.
NEURONES (NRO-PA) has a market capitalization of $884M. It is classified as a small-cap stock.
Yes, NEURONES (NRO-PA) pays a dividend with a trailing twelve-month yield of 3.56%.
Based on historical P/E analysis, NEURONES (NRO-PA) appears cheap. The current P/E of 15.6 is 25% below its historical median of 20.9. The estimated fair value CAGR (P/E method) is 9.0%.
NEURONES (NRO-PA) operates in the Information Technology Services industry, within the Technology sector.
NEURONES (NRO-PA) reported annual revenue of $876 million in its most recent fiscal year, based on SEC EDGAR filings.
NEURONES (NRO-PA) has a net profit margin of 6.5%. This is a modest margin.
NEURONES (NRO-PA) generated $91 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
NEURONES (NRO-PA) has a debt-to-equity ratio of 0.10. This indicates a conservatively financed balance sheet.
NEURONES (NRO-PA) reported earnings per share (EPS) of $2.33 in its most recent fiscal year.
NEURONES (NRO-PA) has a return on equity (ROE) of 14.3%. This indicates moderate shareholder returns.
The Ledger Terminal provides 5 years of financial data for NEURONES (NRO-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NEURONES (NRO-PA) has a book value per share of $16.87, based on its most recent annual SEC filing.